Monoclonal Antibody-Based Therapies for Myasthenia Gravis

Alabbad, S; AlGaeed, M; Sikorski, P; Kaminski, HJ

Kaminski, HJ (corresponding author), George Washington Univ, Dept Neurol, 2150 Penn Ave NW, Washington, DC 20008 USA.

BIODRUGS, 2020; 34 (5): 557

Abstract

Myasthenia gravis (MG) is an autoimmune, neuromuscular disorder that produces disabling weakness through a compromise of neuromuscular transmission. T......

Full Text Link